Latest Stories
Don’t miss our hot and upcoming stories
Unlearn AI’s Breakthroughs in AI-Driven Clinical Development: 2024 Milestones and Future Outlook
San Francisco – December 12, 2024 Unlearn AI has emerged as a leader in AI-powered…
How Unlearn AI Is Increasing the Efficiency of Phase 2 Clinical Trials with AI-Powered TwinRCT
December 11, 2024 Enhanced TwinRCT™ 3.0 Unlearn® has introduced an upgraded version of its AI-driven…
Relation Therapeutics, NVIDIA-Backed AI-Biotech, and GSK Announce Strategic Collaborations to Advance Therapies for Fibrotic Diseases and Osteoarthritis
London, UK – December 10, 2024 Relation, a leader in computational and experimental drug discovery,…
Recursion Reports Promising Interim Data for AI-Designed CDK7 Inhibitor in Ovarian Cancer
Salt Lake City – December 9, 2024 Recursion (Nasdaq: RXRX), a leader in AI-powered drug…




